Harvard Business Review

SEPTEMBER 23, 2014

Take the case of Janssen, the pharmaceuticals arm of Johnson & Johnson, which created a breakthrough innovative program called Immersion. Such as a biomarker initiative, the development of a traceable substance that detects a specific disease, which is now underway. But it does happen.

Innovation 11

Innovation P&L Short-term Company 11

Harvard Business Review

DECEMBER 14, 2015

. “Thanks to meditation I have developed patience.” A colleague had developed a cutting-edge medical device, but the company he had started to develop and sell the device was on the rocks. Peter Cooper, founder of Cooper Investors, attributes his ability to invest wisely to his meditation practice.

CEO 8

CEO Emotional Intelligence Cooper Pharmaceuticals 8

Harvard Business Review

OCTOBER 13, 2011

The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Yet unlike in finance, where distributing risk across institutions is the goal, in drug development the focus is on isolating risk. Researchers also observed increased cooperation and effort among individual players.

Banking 10

Banking Pharmaceuticals Microfinance Risk Management 10

Harvard Business Review

OCTOBER 29, 2012

If the cost of innovation is falling, that should enable more of it from poorer countries, companies or cooperatives. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M. In fact, the costs of developing seminal software algorithms continue to rise, too.

Cost 8

Cost Innovation Wireless Disruptive Innovation 8

Harvard Business Review

MARCH 24, 2017

You are the newly promoted vice president of business development at an oil company. Despite having solid internal anti-corruption rules in place, the pharmaceutical giant wound up facing criminal investigations for bribing doctors and foreign officials , eventually paying a $489 million fine. Picture this. Consider the case of GSK.

Ethics 8

Ethics Company Incentives Policies 8

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

SEPTEMBER 7, 2015

And coaching or mentoring approaches have great merits for personal development, but are hard to scale. From cooperation to competition, a game with multiplayer features taps into the rich culture of board games humans have been playing for centuries. Live pilots are highly realistic but costly, time consuming and risky.

Seminar 8

Seminar Learning Curve Strategy Comparison 8

Harvard Business Review

MARCH 27, 2018

Facebook, at that time, allowed app developers to collect this personal data. ” By that I mean companies that control a key platform which, like a coral reef, attracts to its ecosystem users, sellers, advertisers, software developers, apps, and accessory makers. But this was not the first time its policies were violated.

Company 10

Company Advertising Incentives Engineering 10

Strategy Driven

JANUARY 24, 2011

Plus, as a result of a lack of cross-organizational coordination and cooperation, Nokia wasn’t able to improve its proprietary operating system, Symbian, which would have allowed it to support a more sophisticated smartphone. The BRIDGE that failed for Gap Makers #2, 3, and 4 : Company-Wide Coordination and Cooperation.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

OCTOBER 27, 2015

At UCB, a medium-sized pharmaceutical company headquartered in Belgium, Heresh Rezavandi and his managers Michelle Maddix-Sovero are leading a young strategic intelligence function that’s part of the strategic marketing practice. There are, of course, exceptions — and other companies can learn from them.

Marketing 8

Marketing Competitive Intelligence Porter How To 8

Harvard Business Review

NOVEMBER 28, 2016

The development of targeted therapies and immunotherapies — the two biggest hopes for cancer cures — depend on the existence of large data sets comprising patients’ genetic and clinical information. Efforts like these are likely to improve the ways the members of the precision medicine ecosystem cooperate.

Pharmaceuticals 8

Pharmaceuticals Information Health Care Cooper 8